Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Sumatriptan succinate 6mg injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sumatriptan succinate 12mg/mL injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sumatriptan succinate 25mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely sumatriptan (as sumatriptan succinate) 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sumatriptan 50mg rapid release tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sumatriptan 100mg rapid relase tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sumatriptan (as sumatriptan succinate) 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely sumatriptan succinate 25 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sumatriptan 4mg injection solution prefilled catridge (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sumatriptan 6mg injection solution prefilled cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sumatriptan 6mg/0.5mL injection refill (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely sumatriptan (as sumatriptan succinate) 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sumatriptan (as sumatriptan succinate) 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sumatriptan succinate 25 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sumatriptan succinate 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sumatriptan succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sumatriptan succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely sumatriptan succinate 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Sumatriptan succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sumatriptan (as sumatriptan succinate) 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Sumatriptan succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sumatriptan (as sumatriptan succinate) 50 mg oral tablet |
Has precise active ingredient |
True |
Sumatriptan succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Sumatriptan succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely sumatriptan succinate 12 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Sumatriptan succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sumatriptan succinate 12 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sumatriptan succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |